苹果酸苏尼替尼
Sunitinib malate;SUNITINIB-D4;SUNITINIB MALEATE;1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1);Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);(Z)-N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (S)-2-hydroxysuccinate;Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,...;1-(DIPHENYLMETHYL)-4-HYDROXYAZETIDINE HYDROCHLORIDE; L-malic acid salt of sunitinib;sunitinib L-malic acid salt;sunitynib L-malate;N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate;Sutent;SU011248 L-malate salt;Sunitinib malate [USAN];SU010398;SU 011248;LVX8N1UT73;SU011248;SU 11248;Butanedioic;Butanedioic acid, hy;Sunitinib Malate;(Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide(S)-2-hydroxysuccinate;SUNITINIB MALATE [WHO-DD];SUNITINIB MALATE [ORANGE BOOK];SCHEMBL1772213;N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid;Sunitinib Malate (Sutent);CCG-221818;sunitinib L-malate;341031-54-7;SCHEMBL1258610;PNU-290940AD;SUNITINIB MALATE [JAN];CS-0177;HY-10255;N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide mono((2S)-2-hydroxysuccinate);SW219407-1;KS-5023;SU-11248 L-malate salt;J-019449;NCGC00261199-01;Tox21_112249_1;A822079;Sutent (TN) (Pfizer);Sunitinib Malate (Sunitinib L-Malate);HMS3261H09;LBWFXVZLPYTWQI-IPOVEDGCSA-N;Sunitinib malate- Bio-X;1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1);1H-Pyrrole-3-carboxamide,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1);Sutent (TN);SU-11248J;(Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (S)-2-hydroxysuccinate;(2S)-2-hydroxybutanedioic acid; N-[2-(diethylamino)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide;N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidine)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-2-hydroxybutanedioate salt;Sunitinib malate (JAN/USAN);SUNITINIB MALATE [MI];AKOS005145765;PHA-290940AD;SU-010398;Sunitinib (Malate);1H-Pyrrole-3-carboxamide,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, malate salt;SU112248;N-(2-DI...